Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizushima, N.
Right arrow Articles by Miyasaka, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizushima, N.
Right arrow Articles by Miyasaka, N.
Ann Rheum Dis 1998;57:495-499 ( August )

Extended reports

Ceramide, a mediator of interleukin 1, tumour necrosis factor alpha , as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells Noboru Mizushima, Hitoshi Kohsaka, Nobuyuki Miyasaka

First Department of Internal Medicine, School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan

Correspondence to: Dr H Kohsaka, First Department of Internal Medicine, School of Medicine, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.

Accepted for publication 11 June 1998

OBJECTIVES---To examine the effects of ceramide, which is a lipid second messenger of cell surface receptors, including tumour necrosis factor alpha  (TNFalpha ), interleukin 1 (IL1), and Fas receptors, on rheumatoid arthritis (RA) synovial cells.
METHODS---Synovial cells from RA patients and normal skin fibroblasts were cultured with cell permeable ceramide (C2-ceramide). Apoptosis was assessed by microscopic observation of morphological changes, nuclear staining, and DNA electrophoresis. DNA synthesis was examined by thymidine incorporation.
RESULTS---C2-ceramide induced reversible morphological changes of synovial cells such as cell rounding within four hours. Subsequently, irreversible nuclear changes characteristic to apoptosis were observed at 48 hours. DNA synthesis was not promoted. The addition of ceramide exerted similar effects on cultured dermal fibroblasts.
CONCLUSION---Ceramide induced apoptosis in RA synovial cells. Ceramide could be a second messenger specific for apoptosis of RA synovial cells.

Keywords: ceramide; apoptosis; rheumatoid arthritis


© 1998 by Annals of the Rheumatic Diseases



This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. L. Peng
Fas (CD95)-related apoptosis and rheumatoid arthritis
Rheumatology, January 1, 2006; 45(1): 26 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Drynda, P. H. A. Quax, M. Neumann, W. H. van der Laan, G. Pap, S. Drynda, I. Meinecke, J. Kekow, W. Neumann, T. W. J. Huizinga, et al.
Gene Transfer of Tissue Inhibitor of Metalloproteinases-3 Reverses the Inhibitory Effects of TNF-{alpha} on Fas-Induced Apoptosis in Rheumatoid Arthritis Synovial Fibroblasts
J. Immunol., May 15, 2005; 174(10): 6524 - 6531.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. Nonomura, H. Kohsaka, K. Nasu, Y. Terada, M.-a. Ikeda, and N. Miyasaka
Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21Cip1 gene into the joints
Int. Immunol., June 1, 2001; 13(6): 723 - 731.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. G. Carlson, W. A. Wieggel, J. Chen, A. Bacchi, S. W. Rogers, and L. C. Gahring
Inflammatory Cytokines IL-1{alpha}, IL-1{beta}, IL-6, and TNF-{alpha} Impart Neuroprotection to an Excitotoxin Through Distinct Pathways
J. Immunol., October 1, 1999; 163(7): 3963 - 3968.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1998 BMJ Publishing Group Ltd & European League Against Rheumatism